Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription

Articles published in Histopathology

Retrieve available abstracts of 14 articles:
HTML format
Text format

Single Articles

    March 2018
  1. NOGALES FF, Prat J, Schuldt M, Cruz-Viruel N, et al
    Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
    Histopathology. 2018;72:634-647.
    PubMed     Text format     Abstract available

  2. SINGH P, Kaushal V, Rai B, Rajwanshi A, et al
    The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma.
    Histopathology. 2018;72:619-625.
    PubMed     Text format     Abstract available

  3. ROTH LM, Cheng L
    Classical gonadoblastoma: its relationship to the 'dissecting' variant and undifferentiated gonadal tissue.
    Histopathology. 2018;72:545-555.
    PubMed     Text format     Abstract available

    January 2018
  4. VAN GOOL IC, Ubachs JEH, Stelloo E, de Kroon CD, et al
    Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.
    Histopathology. 2018;72:248-258.
    PubMed     Text format     Abstract available

  5. YU G, Qu G
    High molecular weight caldesmon expression in ovarian adult granulosa cell tumour and fibrothecoma.
    Histopathology. 2018;72:359-361.
    PubMed     Text format    

    June 2017
  6. MCCLUGGAGE WG, Witkowski L, Clarke BA, Foulkes WD, et al
    Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm.
    Histopathology. 2017;70:1147-1154.
    PubMed     Text format     Abstract available

    February 2017
  7. MCINTYRE JB, Rambau PF, Chan A, Yap S, et al
    Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma.
    Histopathology. 2017;70:347-358.
    PubMed     Text format     Abstract available

    January 2017
  8. STEWART CJ, Bowtell DD, Doherty DA, Leung YC, et al
    Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma.
    Histopathology. 2017;70:309-313.
    PubMed     Text format     Abstract available

    October 2016
  9. HOANG LN, Lee YS, Karnezis AN, Tessier-Cloutier B, et al
    Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
    Histopathology. 2016;69:560-9.
    PubMed     Text format     Abstract available

    September 2016
  10. SNIR OL, Buza N, Hui P
    Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study.
    Histopathology. 2016;69:383-92.
    PubMed     Text format     Abstract available

    May 2016
  11. BAKHSH S, Kinloch M, Hoang LN, Soslow RA, et al
    Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.
    Histopathology. 2016;68:916-24.
    PubMed     Text format     Abstract available

  12. HIROSE T, Nobusawa S, Kusanishi H
    Ovarian primitive-type neuroectodermal tumour composed of desmoplastic/nodular medulloblastoma-like and atypical teratoid/rhabdoid tumour components.
    Histopathology. 2016;68:939-42.
    PubMed     Text format    

    March 2016
  13. TAYLOR J, Clarke BA, Hasan NU, Gasljevic G, et al
    Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non-neoplastic remnants?
    Histopathology. 2016;68:596-602.
    PubMed     Text format     Abstract available

  14. KATO N, Kurotaki H, Uchigasaki S, Fukase M, et al
    Ovarian clear cell carcinoma with plasma cell-rich inflammatory stroma: a clear cell carcinoma subgroup with distinct clinicopathological features.
    Histopathology. 2016;68:588-95.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.